3T Biosciences Competitors and Similar CompaniesClear all

3T Biosciences's competitors and similar companies include Eutilex, Zymeworks and Foghorn Therapeutics.

	3T Biosciences 3T Biosciences is an immunotherapy company.	Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date	Founding Date 2017	Founding Date 2015	Founding Date 2003	Founding Date 2016
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech machine learning oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations South San Francisco, US HQ	Locations KR HQ	Locations Vancouver, CA HQ Seattle, US	Locations Cambridge, US HQ Cambridge, US
Employees	Employees 306% decrease	Employees 141	Employees 45519% increase	Employees 1123% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 973.3 m	Valuation ($) 452 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₩9.5b (FY, 2024)	Revenue (est.) $106m (FY, 2025)	Revenue (est.) $30.9m (FY, 2025)
Net income	Net income N/A	Net income (₩29.5b) (FY, 2024)	Net income ($81.1m) (FY, 2025)	Net income ($74.4m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 12m	Total funding raised $ 18.9m	Total funding raised $ 125.9m	Total funding raised $ 50m

For sources of this data, please see the company profile

View Company Profiles

Eutilex

Employees

141

Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.

View company

Zymeworks

Vancouver, CA

Employees

455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company

Foghorn Therapeutics

Cambridge, US

Employees

112↓ 3% decrease

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.